1. Home
  2. Browse
  3. Cardiology
  4. Dyslipidemia
  5. Treatment

Treatment

76 - 90 of 153 Results
Sort Results:
Commentary: New Drug: Praluent (Alirocumab) September 2015
Article: Educate that PCSK9 Inhibitors Haven't Been Proven to Reduce CV Outcomes August 2015
PL Voices: Non-Statins for Dyslipidemia July 2015
Article: Consider Ezetimibe as a Statin Add-On July 2015
PL Voices: Medication Choices after Coronary Artery Bypass Graft (CABG) Surgery May 2015
Article: Be Aware Statin Guidelines Don't Include Younger or Older Patients May 2015
Article: Verify CABG Patients are Started on an ACEI, Beta-Blocker, and Statin May 2015
Checklist: Post-CABG Pharmacotherapy Checklist May 2015
PL Voices: Controversy About the New Cardiovascular Risk Calculator April 2015
Article: Don't Use Diabetes as a CV Risk Equivalent April 2015
Commentary: Statins for Patients with Diabetes April 2015
Toolbox: Reducing Hospital Readmissions March 2015
PL Voices: Role of Ezetimibe (Zetia, etc) for Dyslipidemia January 2015
Article: Save Ezetimibe For Patients Who Don't Tolerate High-Dose Statins January 2015
Commentary: Ezetimibe’s Role in Cardiovascular Risk Reduction January 2015